Literature DB >> 2544108

Kinetics of adenine nucleotide catabolism in coronary circulation of rats.

G Fleetwood1, S B Coade, J L Gordon, J D Pearson.   

Abstract

We have used the rat isolated, perfused heart to study the metabolism of adenine nucleotides on a single passage through the coronary circulation. Low doses (3-30 nmol) of ATP, ADP, or AMP injected as a bolus were extensively catabolized by ectoenzymes. Increasing doses of each nucleotide demonstrated saturability of catabolism that occurred at significantly lower doses of AMP than of ADP or ATP. The patterns of catabolites formed in each case were consistent with the major pathway of metabolism being sequential dephosphorylation of ATP----ADP----AMP----adenosine, although from experiments in which [3H]ATP was co-injected with unlabeled ADP, it appears that some direct conversion of ATP----AMP can occur. Furthermore, particularly in the presence of excess unlabeled ATP, [3H]ADP was phosphorylated to [3H]ATP, indicating that ectoenzymes capable of interconverting nucleotides are present. By evaluating recovery and metabolism in serial samples collected rapidly after bolus injection, we were able to use the integrated form of the Michaelis-Menten equation as developed by Bronikowski et al. (Math. Biosci. 61: 237-266, 1982) to derive Michaelis constant (Km) and maximum velocity times capillary plasma volume (Amax) values for adenosinetriphosphatase, adenosine diphosphatase, and 5'-nucleotidase (450, 300, and 93 microM; and 5.3, 5.9, and 1.7 mumol/min, respectively). This analysis also indicated that there is a high degree of heterogeneity of path lengths within the coronary circulation.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2544108     DOI: 10.1152/ajpheart.1989.256.6.H1565

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  10 in total

Review 1.  Cardiac purinergic signalling in health and disease.

Authors:  Geoffrey Burnstock; Amir Pelleg
Journal:  Purinergic Signal       Date:  2014-12-20       Impact factor: 3.765

2.  Intravascular ATP and coronary vasodilation in the isolated working rat heart.

Authors:  O Korchazhkina; G Wright; C Exley
Journal:  Br J Pharmacol       Date:  1999-06       Impact factor: 8.739

3.  Role of A(2A)-adenosine receptor activation for ATP-mediated coronary vasodilation in guinea-pig isolated heart.

Authors:  K S Erga; C N Seubert; H X Liang; L Wu; J C Shryock; L Belardinelli
Journal:  Br J Pharmacol       Date:  2000-07       Impact factor: 8.739

4.  Effects of pyrimidines on the guinea-pig coronary vasculature.

Authors:  A J Vials; G Burnstock
Journal:  Br J Pharmacol       Date:  1993-11       Impact factor: 8.739

5.  Mathematical model of nucleotide regulation on airway epithelia. Implications for airway homeostasis.

Authors:  Peiying Zuo; Maryse Picher; Seiko F Okada; Eduardo R Lazarowski; Brian Button; Richard C Boucher; Timothy C Elston
Journal:  J Biol Chem       Date:  2008-07-28       Impact factor: 5.157

6.  Characterization of an ATP diphosphohydrolase activity (APYRASE, EC 3.6.1.5) in rat blood platelets.

Authors:  S S Frassetto; R D Dias; J J Sarkis
Journal:  Mol Cell Biochem       Date:  1993-12-08       Impact factor: 3.396

7.  Ecto-5'-nucleotidase is expressed by pericytes and fibroblasts in the rat heart.

Authors:  K Mlodzik; J Loffing; M Le Hir; B Kaissling
Journal:  Histochem Cell Biol       Date:  1995-03       Impact factor: 4.304

8.  Effects of nitric oxide synthase inhibitors, L-NG-nitroarginine and L-NG-nitroarginine methyl ester, on responses to vasodilators of the guinea-pig coronary vasculature.

Authors:  A Vials; G Burnstock
Journal:  Br J Pharmacol       Date:  1992-10       Impact factor: 8.739

9.  Activation of P1- and P2Y-purinoceptors by ADP-ribose in the guinea-pig taenia coli, but not of P2X-purinoceptors in the vas deferens.

Authors:  C H Hoyle; G A Edwards
Journal:  Br J Pharmacol       Date:  1992-10       Impact factor: 8.739

10.  ATP-induced cardioprotection against myocardial ischemia/reperfusion injury is mediated through the RISK pathway.

Authors:  Zhe-Xun Lian; Fang Wang; Jun-Hua Fu; Zuo-Yuan Chen; Hui Xin; Ru-Yong Yao
Journal:  Exp Ther Med       Date:  2016-08-02       Impact factor: 2.447

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.